G01N 33/6878
In epitope analysis
Official title: {in epitope analysis}
G01N33/6878 (In epitope analysis) appears on 313 US grants and 487 published applications in this corpus.
Search patents in G01N- Granted patents
- 313
- Published applications
- 487
- Assignees
- 296
- Inventors
- 1,050
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 3 | 0 |
| 1990 | 2 | 0 |
| 1991 | 3 | 0 |
| 1992 | 1 | 0 |
| 1993 | 9 | 0 |
| 1994 | 2 | 0 |
| 1995 | 6 | 0 |
| 1996 | 6 | 0 |
| 1997 | 7 | 0 |
| 1998 | 12 | 0 |
| 1999 | 10 | 0 |
| 2000 | 7 | 0 |
| 2001 | 7 | 1 |
| 2002 | 6 | 11 |
| 2003 | 9 | 12 |
| 2004 | 7 | 23 |
| 2005 | 6 | 25 |
| 2006 | 9 | 15 |
| 2007 | 3 | 17 |
| 2008 | 10 | 12 |
| 2009 | 11 | 16 |
| 2010 | 8 | 10 |
| 2011 | 6 | 19 |
| 2012 | 6 | 9 |
| 2013 | 4 | 16 |
| 2014 | 8 | 9 |
| 2015 | 8 | 14 |
| 2016 | 6 | 19 |
| 2017 | 13 | 22 |
| 2018 | 11 | 18 |
| 2019 | 11 | 31 |
| 2020 | 17 | 32 |
| 2021 | 12 | 31 |
| 2022 | 14 | 23 |
| 2023 | 15 | 24 |
| 2024 | 15 | 35 |
| 2025 | 14 | 20 |
| 2026 | 5 | 23 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Systems, methods and compositions for analysis of proteoforms7 Jul 2026US 12,674,807 B2Nautilus Subsidiary, Inc.
- Peptide microarrays and novel biomarkers for celiac disease23 Jun 2026US 12,663,418 B2Vibrant Holdings, LLC
- Proinsulin peptides for Type 1 Diabetes2 Jun 2026US 12,643,934 B2King's College London
- Epitope-based approach for allergy treatments and inhibitors for Crohn's disease17 Mar 2026US 12,576,123 B2Psomagen, Inc.
- Neoantigen immunotherapies10 Mar 2026US 12,569,546 B2Iogenetics, LLC
- Quantitative immunoassay for the detection of autoantibodies to nephrin1 Oct 2026US 2026/0298924 A1EUROIMMUN Medizinische Labordiagnostika AG
- Method for measuring polypeptide aggregate, calibrator, complex, and method for producing the same1 Oct 2026US 2026/0298944 A1Sysmex Corporation
- Systems for identifying proteoforms of tau protein24 Sep 2026US 2026/0287600 A1Nautilus Subsidiary, Inc.
- Materials and Methods For Cell-Free Expression of Vaccine Epitope Concatemers27 Aug 2026US 2026/0250332 A1Leidos, Inc.
- Neoantigen immunotherapies20 Aug 2026US 2026/0240970 A1Iogenetics, LLC
Most cited
By later US patents
- Method for determining mimotopes207US 4,833,092 ACommonwealth Serum Laboratories Commission · 1989
- Peptide library and screening systems197US 5,432,018 AAffymax Technologies N.V. · 1995
- Antigenically active amino acid sequences190US 4,708,871 ACommonwealth Serum Laboratories Commission · 1987
- Human growth hormone variants having greater affinity for human growth hormone receptor at site 1133US 5,534,617 AGenentech, Inc. · 1996
- Method and means for sorting and identifying biological information131US 5,866,363 A1999